BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11876993)

  • 1. [In vitro induction of autologous T cell killing by heat treated human chronic myelogenous leukemia cells].
    He X; You S; Bian S; Liao X; Li M; Ma S; Ge W; Qian L
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):287-90. PubMed ID: 11876993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70.
    Wei Y; Zhao X; Kariya Y; Fukata H; Teshigawara K; Uchida A
    Cancer Res; 1996 Mar; 56(5):1104-10. PubMed ID: 8640768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
    Zhao W; Xing P; Wei X; Wang T; Yang D; Li M
    Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cells.
    Lewalle P; Hensel N; Guimaraes A; Couriel D; Jiang Y Z; Mavroudis D; Barrett AJ
    Br J Haematol; 1996 Mar; 92(3):587-94. PubMed ID: 8616022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on T lymphocyte recognition of tumor antigens on autologous CML cells].
    Chen Y; Hao Y; You S; Wei D; Wei D; Liao X; Ding S; Liu S; Wei D
    Zhonghua Xue Ye Xue Za Zhi; 1997 Dec; 18(12):638-41. PubMed ID: 15625763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia.
    Li Z; Qiao Y; Liu B; Laska EJ; Chakravarthi P; Kulko JM; Bona RD; Fang M; Hegde U; Moyo V; Tannenbaum SH; Ménoret A; Gaffney J; Glynn L; Runowicz CD; Srivastava PK
    Clin Cancer Res; 2005 Jun; 11(12):4460-8. PubMed ID: 15958631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of autologous lymphocytes of patients with chronic myelogenous leukemia in the chronic phase with cytokines and CD3 monoclonal antibody results in bcr/abl- blood leukocyte cultures as determined by reverse transcriptase-polymerase chain reaction.
    Krackhardt A; Maurer J; Thiel E; Notter M
    Exp Hematol; 1998 Dec; 26(13):1265-70. PubMed ID: 9845383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
    Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
    Westermann J; Kopp J; van Lessen A; Hecker AC; Baskaynak G; le Coutre P; Döhner K; Döhner H; Dörken B; Pezzutto A
    Br J Haematol; 2007 May; 137(4):297-306. PubMed ID: 17408402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of heat shock protein 70 (Hsp70) and idiotypic determinant single-chain antibody (Id-ScFv) in a patient with B-cell chronic lymphatic leukemia (B-CLL) and antitumor effect of peptide complex Hsp70-Id].
    Ye Q; Wang ZH; Qin SK
    Ai Zheng; 2008 Feb; 27(2):133-8. PubMed ID: 18279608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
    Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
    Schmitt M; Li L; Giannopoulos K; Chen J; Brunner C; Barth T; Schmitt A; Wiesneth M; Döhner K; Döhner H; Greiner J
    Exp Hematol; 2006 Dec; 34(12):1709-19. PubMed ID: 17157168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia.
    Lim SH; Coleman S; Bailey-Wood R
    Bone Marrow Transplant; 1998 Dec; 22(12):1185-90. PubMed ID: 9894722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML.
    Litzow MR; Dietz AB; Bulur PA; Butler GW; Gastineau DA; Hoering A; Fink SR; Letendre L; Padley DJ; Paternoster SF; Tefferi A; Vuk-Pavlović S
    Cytotherapy; 2006; 8(3):290-8. PubMed ID: 16793737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation.
    Gross C; Holler E; Stangl S; Dickinson A; Pockley AG; Asea AA; Mallappa N; Multhoff G
    Leuk Res; 2008 Apr; 32(4):527-34. PubMed ID: 17543383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of leukemia-specific antibodies by immunotherapy with leukemia-cell-derived heat shock protein 70.
    Jimbo J; Sato K; Hosoki T; Shindo M; Ikuta K; Torimoto Y; Kohgo Y
    Cancer Sci; 2008 Jul; 99(7):1427-34. PubMed ID: 18452562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study on the expression of membrane HSP70 protein in H22 cell and its immunoprotective mechanism against carcinoma.
    Wu WZ; Liu KD; Xie Q; Wu HS
    J Exp Clin Cancer Res; 1999 Dec; 18(4):543-8. PubMed ID: 10746982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.